GSK confirmed this morning that the disappointing readout from the DREAMM-3 trial of multiple myeloma therapy Blenrep reported earlier this month means that it will take the drug off the US market.

One of the highest-odds plays for a dominant gobbler now is to simply park yourself in a spot where you know a henned-up tom likes to strut or where hens will go to feed or dust, as the toms will ...

In response to the U.S.’s bombing of Iran’s nuclear sites on Saturday, Central Oregon 50501 organized a protest on Sunday at downtown Bend’s Peace… ...